Intelligent Control High Flow Nasal Cannula Device For Respiratory Dept.

Micomme medical high flow device with oxygen therapy 60A

Description

High-flow nasal cannula (HFNC) therapy is an oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a high flow rate per minute.

HFNC is a promising novel oxygen delivery device, whose mechanisms of action offer some beneficial effects over conventional oxygen systems. It is considered to have a number of physiological effects: it improves oxygenation, dynamic lung compliance, homogeneity and end expiratory lung volume; it decreases anatomical dead space and generates a positive airway pressure that can reduce respiratory rate, the work of breathing, and enhance patient comfort.

Application

Acute hypoxic respiratory failure (ARF) was the first condition treated with HFNC in adults. The use of heated and humidified high flow nasal cannula (HFNC) has become increasingly popular in the treatment of patients with acute respiratory failure through all age groups.

When HFNC is used to deliver oxygen, the flow rates are much higher than can be achieved with traditional nasal cannula. This results in a greater delivery of prescribed oxygen into the lungs, and less entrainment of room air. The oxygen you want to deliver to your patients is not prone to the same effect of dilution!

Advantage

During the pandemic, micomme provided over 7000 units of devices globally.

At present, micomme occupies over 50% market share in high flow filed in China.

Built-in oxygen-gas mixture to accurately control oxygen and adjust oxygen concentration.

Temperature can be adjusted precisely.

Intelligent temperature and humidity control system.

Specifications